NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in NRX Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +3 vs. Q1 2022
- Shares held
- 3.64M
- −6.62M (−64.5%) vs. Q1 2022
- Total value
- $2.18M
- −$23.0M (−91.3%) vs. Q1 2022
- New holders
- 8
- 12 more added
- Sold out
- 5
- 8 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $47.6M |
| Q1 2026 | 33 | $13.2M |
| Q4 2025 | 28 | $14.2M |
| Q3 2025 | 24 | $13.0M |
| Q2 2025 | 25 | $9.76M |
| Q1 2025 | 22 | $4.60M |
| Q4 2024 | 25 | $2.31M |
| Q3 2024 | 18 | $1.21M |
| Q2 2024 | 19 | $1.29M |
| Q1 2024 | 31 | $1.76M |
| Q4 2023 | 30 | $1.84M |
| Q3 2023 | 34 | $964.7K |
| Q2 2023 | 32 | $4.78M |
| Q1 2023 | 30 | $2.07M |
| Q4 2022 | 33 | $3.44M |
| Q3 2022 | 30 | $3.04M |
| Q2 2022 | 37 | $2.18M |
| Q1 2022 | 34 | $25.1M |
| Q4 2021 | 38 | $12.4M |
| Q3 2021 | 23 | $16.2M |
| Q2 2021 | 18 | $18.9M |
| Q1 2021 | 1 | $4.00K |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding NRX Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,094,713 | $657.0K | 0.00% | +19,396+1.8% | Added |
| BlackRock Inc. | 652,315 | $391.0K | 0.00% | +126,822+24.1% | Added |
| Geode Capital Management, LLC | 308,432 | $185.0K | 0.00% | +14,565+5.0% | Added |
| Millennium Management LLC | 296,815 | $178.0K | 0.00% | +296,815 | New |
| Sabby Management, LLC | 200,000 | $120.0K | 0.22% | −582,473−74.4% | Reduced |
| Group One Trading, L.P. | 172,923 | $104.0K | 0.00% | +139,035+410.3% | Added |
| Bridgeway Capital Management, LLC | 153,700 | $92.0K | 0.00% | +153,700 | New |
| State Street Corp | 114,240 | $69.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 91,666 | $55.0K | 0.00% | +91,666 | New |
| Susquehanna International Group, LLP | 87,574 | $53.0K | 0.00% | +56,965+186.1% | Added |
| Northern Trust Corp | 58,598 | $35.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 56,365 | $33.0K | 0.00% | +4,568+8.8% | Added |
| Owl Creek Asset Management, L.P. | 50,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 41,451 | $25.0K | 0.00% | +41,451 | New |
| HighPoint Advisor Group LLC | 43,501 | $24.0K | 0.00% | +43,501 | New |
| Renaissance Technologies LLC | 32,900 | $20.0K | 0.00% | −106,103−76.3% | Reduced |
| Wolverine Asset Management LLC | 28,013 | $16.0K | 0.00% | −6,375−18.5% | Reduced |
| Goldman Sachs Group Inc | 22,512 | $14.0K | 0.00% | +1,218+5.7% | Added |
| United Asset Strategies, Inc. | 18,300 | $11.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 18,305 | $11.0K | 0.00% | +9,125+99.4% | Added |
| UBS Group AG | 16,798 | $10.0K | 0.00% | +12,271+271.1% | Added |
| Virtu Financial LLC | 12,799 | $8.00K | 0.00% | +12,799 | New |
| Wealthcare Advisory Partners LLC | 13,000 | $8.00K | 0.00% | +13,000 | New |
| Davenport & Co LLC | 10,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 10,129 | $6.00K | 0.00% | 00.0% | Unchanged |
| Penserra Capital Management LLC | 10,157 | $6.00K | 0.00% | +3,748+58.5% | Added |
| Exchange Traded Concepts, LLC | 9,402 | $6.00K | 0.00% | +7,508+396.4% | Added |
| Wells Fargo & Company | 5,232 | $3.00K | 0.00% | +232+4.6% | Added |
| Tower Research Capital LLC (TRC) | 4,053 | $2.00K | 0.00% | −1,081−21.1% | Reduced |
| Citigroup Inc | 976 | $1.00K | 0.00% | −14,232−93.6% | Reduced |
| JPMorgan Chase & Co | 1,954 | $1.00K | 0.00% | −4,998−71.9% | Reduced |
| Cutler Group LP | 3,220 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 561 | $0 | 0.00% | −17,159−96.8% | Reduced |
| Bank of America Corp | 320 | $0 | 0.00% | −1,167−78.5% | Reduced |
| Larson Financial Group LLC | 218 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 172 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 523 | $0 | 0.00% | +523 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −6,259,781−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −625,978−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −20,541−100.0% | Sold out |
| Ursa Fund Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |